Categories
AHC Research

New gene therapy gives hope

Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, Atp1a3Mashl/+, Mouse Model of Alternating Hemiplegia of Childhood Arsen S. Hunanyan, Boris Kantor, Ram S. Puranam, Courtney Elliott, Angela McCall, Justin Dhindsa, Promila Pagadala, Keri Wallace, Jordan Poe, Talha Gunduz, Aravind Asokan, Dwight D. Koeberl, Mai K. ElMallah, and Mohamad A. Mikati Abstract Alternating Hemiplegia of Childhood (AHC) is a devastating autosomal dominant disorder caused by ATP1A3 mutations, resulting in severe hemiplegia and dystonia […]

Categories
AHC Research Iceland

The 8th Annual Symposium on ATP1A3 in Disease

The 8th Annual Symposium on ATP1A3 in Disease 2019 will take place 3 – 4 October 2019 at the beautiful and conveniently located Grand Hotel Reykjavík on Iceland. The host this year is the AHC Association of Iceland supported by an organising committee that consist of European scientists that have been working on ATP1A3 related […]

Categories
AHC Research

AAV Project update

March 5, 2019 – Joint message from Cure AHC, AHC Foundation and Hope for Annabel: To pick an analogy for this second AAV Project update, we would say that it is like preparing for space travel. We have the captain and crew, but before we start the countdown we need to make sure our rocket […]

Categories
AHC Research

Symposium on AHC in Barcelona

AESHA (the Spanish AHC association) is hosting a Symposium on AHC in Barcelona on February 9th 2019. The program is very interesting and registration is free  

Categories
AHC Research

ATP1A3 Symposium in Disease in Iceland 2019

The 8th symposium on ATP1A3 will be held in Reykjavik, Iceland October 3-4th 2019. President of Iceland will open the symposium and Kari Stefansson CEO of DeCode will present. It will be a symposium worth joining and we will have research result from many fantastic researchers. http://conferences.au.dk/atp1a3symposium2019/

Categories
AHC Research

AHCFE is a member of Eurordis

AHC Federation of Europe is a member of Eurordis and volunteers as experts in two groups within Eurordis: Drug Information, Transparency and Access task force (DITA) The Drug Information, Transparency and Access (DITA) Task Force closely follows the work done by patients and consumers at the European Medicines Agency (EMA) and in the European Network […]